CARLSBAD, Calif. (AP) _ Lineage Cell Therapeutics, Inc. (LCTX) on Thursday reported a loss of $6.8 million in its second quarter.

On a per-share basis, the Carlsbad, California-based company said it had a loss of 4 cents.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.

The biotechnology company posted revenue of $4.6 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $4.9 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LCTX at https://www.zacks.com/ap/LCTX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News